LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Momelotinib | 0.04 | uM | LJP5 | 1 | P12 | 72 | hr | 1235 | 3910 | 4474 | 0.8738 | 0.8598 |
MDA-MB-231 | Momelotinib | 0.04 | uM | LJP5 | 2 | P12 | 72 | hr | 1235 | 3843 | 4578 | 0.8393 | 0.8229 |
MDA-MB-231 | Momelotinib | 0.04 | uM | LJP5 | 3 | P12 | 72 | hr | 1235 | 4524 | 4929 | 0.9178 | 0.9158 |
MDA-MB-231 | Momelotinib | 0.12 | uM | LJP5 | 1 | P11 | 72 | hr | 1235 | 3351 | 4474 | 0.7489 | 0.7115 |
MDA-MB-231 | Momelotinib | 0.12 | uM | LJP5 | 2 | P11 | 72 | hr | 1235 | 3183 | 4578 | 0.6952 | 0.6499 |
MDA-MB-231 | Momelotinib | 0.12 | uM | LJP5 | 3 | P11 | 72 | hr | 1235 | 4163 | 4929 | 0.8445 | 0.8377 |
MDA-MB-231 | Momelotinib | 0.37 | uM | LJP5 | 1 | P10 | 72 | hr | 1235 | 2758 | 4474 | 0.6164 | 0.5410 |
MDA-MB-231 | Momelotinib | 0.37 | uM | LJP5 | 2 | P10 | 72 | hr | 1235 | 2836 | 4578 | 0.6194 | 0.5521 |
MDA-MB-231 | Momelotinib | 0.37 | uM | LJP5 | 3 | P10 | 72 | hr | 1235 | 3317 | 4929 | 0.6729 | 0.6399 |
MDA-MB-231 | Momelotinib | 1.11 | uM | LJP5 | 1 | P09 | 72 | hr | 1235 | 1925 | 4474 | 0.4302 | 0.2696 |
MDA-MB-231 | Momelotinib | 1.11 | uM | LJP5 | 2 | P09 | 72 | hr | 1235 | 1997 | 4578 | 0.4362 | 0.2891 |
MDA-MB-231 | Momelotinib | 1.11 | uM | LJP5 | 3 | P09 | 72 | hr | 1235 | 2404 | 4929 | 0.4877 | 0.3956 |
MDA-MB-231 | Momelotinib | 3.33 | uM | LJP5 | 1 | P08 | 72 | hr | 1235 | 1222 | 4474 | 0.2731 | -0.0061 |
MDA-MB-231 | Momelotinib | 3.33 | uM | LJP5 | 2 | P08 | 72 | hr | 1235 | 1308 | 4578 | 0.2857 | 0.0304 |
MDA-MB-231 | Momelotinib | 3.33 | uM | LJP5 | 3 | P08 | 72 | hr | 1235 | 1488 | 4929 | 0.3019 | 0.0975 |
MDA-MB-231 | Momelotinib | 10 | uM | LJP5 | 1 | P07 | 72 | hr | 1235 | 483 | 4474 | 0.1079 | -0.3972 |
MDA-MB-231 | Momelotinib | 10 | uM | LJP5 | 2 | P07 | 72 | hr | 1235 | 565 | 4578 | 0.1234 | -0.3392 |
MDA-MB-231 | Momelotinib | 10 | uM | LJP5 | 3 | P07 | 72 | hr | 1235 | 675 | 4929 | 0.1369 | -0.2615 |
MDA-MB-231 | Fedratinib | 0.04 | uM | LJP5 | 1 | L06 | 72 | hr | 1235 | 3943 | 4474 | 0.8812 | 0.8682 |
MDA-MB-231 | Fedratinib | 0.04 | uM | LJP5 | 2 | L06 | 72 | hr | 1235 | 4326 | 4578 | 0.9448 | 0.9408 |
MDA-MB-231 | Fedratinib | 0.04 | uM | LJP5 | 3 | L06 | 72 | hr | 1235 | 4900 | 4929 | 0.9941 | 0.9940 |
MDA-MB-231 | Fedratinib | 0.12 | uM | LJP5 | 1 | L05 | 72 | hr | 1235 | 3568 | 4474 | 0.7974 | 0.7703 |
MDA-MB-231 | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 1235 | 4027 | 4578 | 0.8795 | 0.8686 |
MDA-MB-231 | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 1235 | 4511 | 4929 | 0.9151 | 0.9131 |
MDA-MB-231 | Fedratinib | 0.37 | uM | LJP5 | 1 | L04 | 72 | hr | 1235 | 3096 | 4474 | 0.6919 | 0.6400 |